ZYUS
ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.
About ZYUS
ZYUS is a biopharmaceutical company that offers patients cannabinoids and other phytotherapeutic medical solutions. The company elevates cannabinoids as a medical solution to alleviate suffering in patients who are experiencing discomfort due to chronic disease, treatment side effects, or conditions related to aging. It aims is to shift the paradigm from the treatment of physical disease to caring for overall well-being, by accelerating the adoption of phytotherapeutics. The company uses science as a driver to establish phytotherapeutics as a standard of care for treating disease and managing the experience of it. The company was founded in 2018 and is headquartered in Saskatoon, Saskatchewan.
Company Facts
- Headquarters
- Saskatoon
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00051_00100
- Funding Stage
- ipo
- Total Funding
- $40,817,025
- Last Funding Type
- post_ipo_debt
- Last Funding Date
- 2026-03-05
- Website
- zyus.com
Industries & Categories
Biopharma, Biotechnology, Cannabis, Health Care, Life Science, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/zyus-92729 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.